synergene active ingredients

systematic approach for innovation

Welcome to About us


Synergene Active Ingredients Pvt. Ltd was commissioned in 2006 and commercial manufacturing started in the same year. Synergene manufactures and supplies Active Pharmaceuticals Ingredients (API'S) for wide range of therapeutic categories. The segments of focus are Anti Fungal, Anti Depressants, Anti Migraine. Anti Glaucoma, Anti Hypertensive’s, Analgesic, Anti Histaminic, Anti Biotic, Premature Ejaculation, Nootropic and Cardio Vascular.

Synergene manufacturing facilities are cGMP compliant meeting applicable regulatory standards in terms of infrastructure and Quality Management systems. The company has two manufacturing facilities located at Hyderabad, Vishakhapatnam & recently, a 60 million dollar “Green Field Project” initiated at Visakhapatnam (Unit-III) manufacturing Active Pharmaceutical Ingredients and Intermediates. The company has a presence in domestic and international markets. The company also exports its products to Germany etc,.

Synergene Active Ingredients Pvt. Ltd continues to reinforce its position to become a major strategic partner by creating exceptional value for our customers in the global market. Underlying this success is the philosophy of consistent high quality, effective blend of technical expertise and experience, organizational strengths, willingness to invest in infrastructure and ability to work closely with diverse clientele worldwide.

Synergene Active Ingredients Pvt.Ltd, is committed to provide "Active Pharmaceutical Ingredients" and "Intermediates Chemicals" of the highest Quality standards to the entire satisfaction of our customers worldwide.

Synergene is an ISO 9001:2008, GMP and WHO GMP certified company, CEP Holder and USFDA Inspected Facility. Synergene is building on the strength of vertical integration in research, process, API manufacturing, development and commercialization. Synergene is research driven APIs Company having global aspirations. The company is moving towards this goal by seeking regulatory approvals and filing DMFs.  The R&D is constantly striving for innovation.